Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Teva
Queensland Health
Mallinckrodt
Federal Trade Commission
Dow
Chubb
Cerilliant
UBS
Fuji

Generated: February 23, 2018

DrugPatentWatch Database Preview

DESOXIMETASONE - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for desoximetasone and what is the scope of desoximetasone patent protection?

Desoximetasone
is the generic ingredient in three branded drugs marketed by Actavis Mid Atlantic, Akorn, Fougera Pharms, Lupin Atlantis, Perrigo New York, Taro, Rising Pharms Inc, Altana, G And W Labs Inc, Glenmark Generics, Novel Labs Inc, Perrigo Israel, Teligent Pharma Inc, and Zydus Pharms Usa Inc, and is included in thirty-four NDAs. There are three patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Desoximetasone has four patent family members in four countries.

There are seven drug master file entries for desoximetasone. Seventeen suppliers are listed for this compound.
Summary for DESOXIMETASONE
Pharmacology for DESOXIMETASONE
Medical Subject Heading (MeSH) Categories for DESOXIMETASONE

US Patents and Regulatory Information for DESOXIMETASONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro TOPICORT desoximetasone OINTMENT;TOPICAL 074286-001 Jun 7, 1996 AB RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lupin Atlantis DESOXIMETASONE desoximetasone CREAM;TOPICAL 208163-001 Jan 10, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Zydus Pharms Usa Inc DESOXIMETASONE desoximetasone OINTMENT;TOPICAL 205206-001 Sep 19, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
G And W Labs Inc DESOXIMETASONE desoximetasone OINTMENT;TOPICAL 206740-001 Dec 23, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Taro TOPICORT desoximetasone GEL;TOPICAL 018586-001 Mar 29, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Altana DESOXIMETASONE desoximetasone OINTMENT;TOPICAL 073440-001 Apr 1, 1998 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lupin Atlantis DESOXIMETASONE desoximetasone OINTMENT;TOPICAL 208044-001 Dec 12, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Actavis Mid Atlantic DESOXIMETASONE desoximetasone OINTMENT;TOPICAL 204965-001 Nov 7, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Akorn DESOXIMETASONE desoximetasone CREAM;TOPICAL 203234-001 Jun 12, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Taro TOPICORT desoximetasone CREAM;TOPICAL 073210-001 Nov 30, 1990 AB RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for DESOXIMETASONE

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
5,886,038 Composition and method for treatment of psoriasis ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Dow
US Department of Justice
Johnson and Johnson
Healthtrust
Baxter
McKinsey
Daiichi Sankyo
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot